Difference between revisions of "Part:BBa K2918020"
Weronika77 (Talk | contribs) (→Toxicity) |
Weronika77 (Talk | contribs) (→Toxicity) |
||
Line 17: | Line 17: | ||
<li style="display: inline-block;"> [[File:T--TUDelft--noiptgdnap.png|thumb|none|444px|<b>Figure 3A:</b> The growth curve of phi29 DNAP under different promoter strengths (weak, medium, Wild-Type) with no IPTG induction]] </li> | <li style="display: inline-block;"> [[File:T--TUDelft--noiptgdnap.png|thumb|none|444px|<b>Figure 3A:</b> The growth curve of phi29 DNAP under different promoter strengths (weak, medium, Wild-Type) with no IPTG induction]] </li> | ||
<li style="display: inline-block;"> [[File:T--TUDelft--dnap1iptg.png|thumb|none|444px|<b>Figure 3B:</b> The growth curve of phi29 DNAP under different promoter strengths (weak, medium, Wild-Type) with 1 mM IPTG induction]] </li> | <li style="display: inline-block;"> [[File:T--TUDelft--dnap1iptg.png|thumb|none|444px|<b>Figure 3B:</b> The growth curve of phi29 DNAP under different promoter strengths (weak, medium, Wild-Type) with 1 mM IPTG induction]] </li> | ||
− | <li> [[File:T--TUDelft--dnap10iptg.png|thumb| | + | <li> [[File:T--TUDelft--dnap10iptg.png|thumb|center|444px|<b>Figure 3C:</b> The growth curve of phi29 DNAP under different promoter strengths (weak, medium, Wild-Type) with 10 mM IPTG induction]] </li> |
</ul></div> | </ul></div> | ||
Revision as of 21:25, 6 December 2019
Weak T7 promoter - Universal RBS - Φ29 DNAP - T7 terminator
A level 1 construct with a 0.1 T7 p, a universal RBS, DNAP and a T7 terminator.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 1709
- 1000COMPATIBLE WITH RFC[1000]
The construct is confirmed by sequencing and there are no mutations.
Toxicity
Our Sci-Phi 29 tool is based on four components of the Φ29 bacteriophage: DNAP, TP, p5 and p6. However, overexpression of these proteins are toxic for the cell. In order to determine the optimal expression levels of the proteins in live cells, we carried out viability assays in E. coli BL21(DE3) pLysS. The results are shown in the graphs below.